MarketCap
Facebook
X
Telegram
AbbVie Kurzfristige Verbindlichkeiten | ABBV
Kurzfristige Verbindlichkeiten Jährlich AbbVie
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.3 B | 38.7 B | 37.8 B | 29.5 B | 35.2 B | 28.7 B | 15.6 B | 17.2 B | 16.6 B | 9.78 B | 10.9 B | 11.4 B | 6.88 B | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 43.3 B | 6.88 B | 23.2 B |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
DiaMedica Therapeutics
DMAC
|
5.13 M | $ 9.47 | 4.76 % | $ 445 M |  USA |
 |
Royalty Pharma plc
RPRX
|
636 M | $ 67.31 | -0.39 % | $ 28.9 B | USA |
 |
Checkpoint Therapeutics
CKPT
|
20.1 M | - | - | $ 169 M | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
106 M | $ 111.51 | 6.18 % | $ 7.25 B | USA |
 |
Puma Biotechnology
PBYI
|
81.3 M | $ 8.28 | -15.25 % | $ 414 M | USA |
 |
SIGA Technologies
SIGA
|
18 M | $ 3.12 | 4.55 % | $ 223 M | USA |
 |
Sage Therapeutics
SAGE
|
71.6 M | - | - | $ 527 M | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
386 M | - | - | $ 1.62 B |  Israel |
 |
Sol-Gel Technologies Ltd.
SLGL
|
6.17 M | $ 61.62 | -2.21 % | $ 172 M | Israel |
 |
SELLAS Life Sciences Group
SLS
|
7.02 M | $ 8.41 | 6.73 % | $ 917 M | USA |
 |
Summit Therapeutics
SMMT
|
73 M | $ 16.34 | 15.15 % | $ 12.2 B |  Britain |
 |
Cabaletta Bio
CABA
|
50.2 M | $ 1.3 | 1.17 % | $ 131 M | USA |
 |
Syndax Pharmaceuticals
SNDX
|
120 M | $ 9.53 | 1.39 % | $ 826 M | USA |
 |
Forma Therapeutics Holdings
FMTX
|
35.1 M | - | - | $ 958 M | USA |
 |
Blueprint Medicines Corporation
BPMC
|
261 M | - | - | $ 8.14 B | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
949 M | - | - | $ 26.6 B |  Irlanda |
 |
Sarepta Therapeutics
SRPT
|
1.1 B | $ 17.8 | 0.68 % | $ 1.78 B | USA |
 |
Paratek Pharmaceuticals
PRTK
|
37.4 M | - | - | $ 121 M | USA |
 |
China SXT Pharmaceuticals
SXTC
|
4.35 M | $ 2.84 | -3.07 % | $ 1.93 M |  China |
 |
Tarsus Pharmaceuticals
TARS
|
136 M | $ 68.11 | 0.87 % | $ 2.85 B | USA |
 |
Bio-Techne Corporation
TECH
|
164 M | $ 72.78 | 0.17 % | $ 11.4 B | USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
13.5 B | $ 42.32 | 1.33 % | $ 48.5 B | Israel |
 |
Adverum Biotechnologies
ADVM
|
22.9 M | - | - | $ 86.2 M | USA |
 |
Unity Biotechnology
UBX
|
9.26 M | - | -33.41 % | $ 3.37 M | USA |
 |
iTeos Therapeutics
ITOS
|
40.4 M | - | - | $ 411 M | USA |
 |
Shattuck Labs
STTK
|
7.05 M | $ 4.59 | 2.78 % | $ 319 M | USA |
 |
Seelos Therapeutics
SEEL
|
38.9 M | - | -47.76 % | $ 6.27 M | USA |
 |
Advaxis
ADXS
|
25 M | - | -9.65 % | $ 45.9 M | USA |
 |
Protara Therapeutics
TARA
|
10.9 M | $ 2.33 | 9.15 % | $ 99.8 M | USA |
 |
Trevi Therapeutics
TRVI
|
9.75 M | $ 14.33 | 11.87 % | $ 1.93 B | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
2.84 M | $ 4.63 | 21.05 % | $ 20 M | Israel |
 |
Fennec Pharmaceuticals
FENC
|
10.5 M | $ 9.79 | 4.26 % | $ 280 M | USA |
 |
Kiromic BioPharma
KRBP
|
20.9 M | - | 6.61 % | $ 3.08 M | USA |
 |
CNS Pharmaceuticals
CNSP
|
4.1 M | $ 3.92 | -2.24 % | $ 1.74 M | USA |
 |
Calithera Biosciences
CALA
|
7.39 M | - | -10.95 % | $ 876 K | USA |
 |
United Therapeutics Corporation
UTHR
|
561 M | $ 562.14 | -0.63 % | $ 24.9 B | USA |
 |
Vericel Corporation
VCEL
|
49.1 M | $ 54.56 | 5.36 % | $ 2.75 B | USA |
 |
Veracyte
VCYT
|
59.9 M | $ 24.1 | 0.42 % | $ 1.89 B | USA |
|
Applied Molecular Transport
AMTI
|
15.1 M | - | - | $ 10.1 M | USA |
 |
Fulcrum Therapeutics
FULC
|
13 M | $ 3.72 | 0.95 % | $ 236 M | USA |
 |
Molecular Templates
MTEM
|
17.3 M | - | -23.43 % | $ 495 K | USA |
 |
Vanda Pharmaceuticals
VNDA
|
145 M | $ 3.82 | 6.27 % | $ 225 M | USA |
 |
Verrica Pharmaceuticals
VRCA
|
16.4 M | $ 3.22 | 4.21 % | $ 34.3 M | USA |
 |
Viridian Therapeutics
VRDN
|
70.7 M | $ 28.47 | -0.28 % | $ 2.9 B | USA |
 |
BioXcel Therapeutics
BTAI
|
53.9 M | $ 0.07 | 9.81 % | $ 855 K | USA |